Cargando…

Caspar Controls Resistance to Plasmodium falciparum in Diverse Anopheline Species

Immune responses mounted by the malaria vector Anopheles gambiae are largely regulated by the Toll and Imd (immune deficiency) pathways via the NF-kappaB transcription factors Rel1 and Rel2, which are controlled by the negative regulators Cactus and Caspar, respectively. Rel1- and Rel2-dependent tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Garver, Lindsey S., Dong, Yuemei, Dimopoulos, George
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2647737/
https://www.ncbi.nlm.nih.gov/pubmed/19282971
http://dx.doi.org/10.1371/journal.ppat.1000335
_version_ 1782164935825948672
author Garver, Lindsey S.
Dong, Yuemei
Dimopoulos, George
author_facet Garver, Lindsey S.
Dong, Yuemei
Dimopoulos, George
author_sort Garver, Lindsey S.
collection PubMed
description Immune responses mounted by the malaria vector Anopheles gambiae are largely regulated by the Toll and Imd (immune deficiency) pathways via the NF-kappaB transcription factors Rel1 and Rel2, which are controlled by the negative regulators Cactus and Caspar, respectively. Rel1- and Rel2-dependent transcription in A. gambiae has been shown to be particularly critical to the mosquito's ability to manage infection with the rodent malaria parasite Plasmodium berghei. Using RNA interference to deplete the negative regulators of these pathways, we found that Rel2 controls resistance of A. gambiae to the human malaria parasite Plasmodium falciparum, whereas Rel 1 activation reduced infection levels. The universal relevance of this defense system across Anopheles species was established by showing that caspar silencing also prevents the development of P. falciparum in the major malaria vectors of Asia and South America, A. stephensi and A. albimanus, respectively. Parallel studies suggest that while Imd pathway activation is most effective against P. falciparum, the Toll pathway is most efficient against P. berghei, highlighting a significant discrepancy between the human pathogen and its rodent model. High throughput gene expression analyses identified a plethora of genes regulated by the activation of the two Rel factors and revealed that the Toll pathway played a more diverse role in mosquito biology than the Imd pathway, which was more immunity-specific. Further analyses of key anti-Plasmodium factors suggest they may be responsible for the Imd pathway–mediated resistance phenotype. Additionally, we found that the fitness cost caused by Rel2 activation through caspar gene silencing was undetectable in sugar-fed, blood-fed, and P. falciparum-infected female A. gambiae, while activation of the Toll pathway's Rel1 had a major impact. This study describes for the first time a single gene that influences an immune mechanism that is able to abort development of P. falciparum in Anopheline species. Further, this study addresses aspects of the molecular, evolutionary, and physiological consequences of the observed phenotype. These findings have implications for malaria control since broad-spectrum immune activation in diverse anopheline species offers a viable and strategic approach to develop novel malaria control methods worldwide.
format Text
id pubmed-2647737
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-26477372009-03-13 Caspar Controls Resistance to Plasmodium falciparum in Diverse Anopheline Species Garver, Lindsey S. Dong, Yuemei Dimopoulos, George PLoS Pathog Research Article Immune responses mounted by the malaria vector Anopheles gambiae are largely regulated by the Toll and Imd (immune deficiency) pathways via the NF-kappaB transcription factors Rel1 and Rel2, which are controlled by the negative regulators Cactus and Caspar, respectively. Rel1- and Rel2-dependent transcription in A. gambiae has been shown to be particularly critical to the mosquito's ability to manage infection with the rodent malaria parasite Plasmodium berghei. Using RNA interference to deplete the negative regulators of these pathways, we found that Rel2 controls resistance of A. gambiae to the human malaria parasite Plasmodium falciparum, whereas Rel 1 activation reduced infection levels. The universal relevance of this defense system across Anopheles species was established by showing that caspar silencing also prevents the development of P. falciparum in the major malaria vectors of Asia and South America, A. stephensi and A. albimanus, respectively. Parallel studies suggest that while Imd pathway activation is most effective against P. falciparum, the Toll pathway is most efficient against P. berghei, highlighting a significant discrepancy between the human pathogen and its rodent model. High throughput gene expression analyses identified a plethora of genes regulated by the activation of the two Rel factors and revealed that the Toll pathway played a more diverse role in mosquito biology than the Imd pathway, which was more immunity-specific. Further analyses of key anti-Plasmodium factors suggest they may be responsible for the Imd pathway–mediated resistance phenotype. Additionally, we found that the fitness cost caused by Rel2 activation through caspar gene silencing was undetectable in sugar-fed, blood-fed, and P. falciparum-infected female A. gambiae, while activation of the Toll pathway's Rel1 had a major impact. This study describes for the first time a single gene that influences an immune mechanism that is able to abort development of P. falciparum in Anopheline species. Further, this study addresses aspects of the molecular, evolutionary, and physiological consequences of the observed phenotype. These findings have implications for malaria control since broad-spectrum immune activation in diverse anopheline species offers a viable and strategic approach to develop novel malaria control methods worldwide. Public Library of Science 2009-03-13 /pmc/articles/PMC2647737/ /pubmed/19282971 http://dx.doi.org/10.1371/journal.ppat.1000335 Text en Garver et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Garver, Lindsey S.
Dong, Yuemei
Dimopoulos, George
Caspar Controls Resistance to Plasmodium falciparum in Diverse Anopheline Species
title Caspar Controls Resistance to Plasmodium falciparum in Diverse Anopheline Species
title_full Caspar Controls Resistance to Plasmodium falciparum in Diverse Anopheline Species
title_fullStr Caspar Controls Resistance to Plasmodium falciparum in Diverse Anopheline Species
title_full_unstemmed Caspar Controls Resistance to Plasmodium falciparum in Diverse Anopheline Species
title_short Caspar Controls Resistance to Plasmodium falciparum in Diverse Anopheline Species
title_sort caspar controls resistance to plasmodium falciparum in diverse anopheline species
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2647737/
https://www.ncbi.nlm.nih.gov/pubmed/19282971
http://dx.doi.org/10.1371/journal.ppat.1000335
work_keys_str_mv AT garverlindseys casparcontrolsresistancetoplasmodiumfalciparumindiverseanophelinespecies
AT dongyuemei casparcontrolsresistancetoplasmodiumfalciparumindiverseanophelinespecies
AT dimopoulosgeorge casparcontrolsresistancetoplasmodiumfalciparumindiverseanophelinespecies